Top

Published in:

01-04-2003 | Article selection

Articles selected from Faculty of 1000 in March 2003

Author: Valerie Speirs

Published in: Breast Cancer Research | Issue 2/2003

Salomon AR, Ficarro SB, Brill LM, Brinker A, Phung QT, Ericson C, Sauer K, Brock A, Horn DM, Schultz PG, Peters EC: Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci U S A. 2003, 100: 443-448. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr592.asp#salomon CrossRefPubMedPubMedCentral

Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR: DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet. 2003, 33: 61-65. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr592.asp#robert CrossRefPubMed

Park SH, Zarrinpar A, Lim WA: Rewiring MAP Kinase Pathways Using Alternative Scaffold Assembly Mechanisms. Science. 2003, 299: 1061-1064. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr592.asp#park CrossRefPubMed

Dahlberg JE, Lund E, Goodwin EB: Nuclear translation: What is the evidence?. RNA. 2003, 1: 1-8. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr592.asp#dahlberg CrossRef

Finke D, Luther SA, Acha-Orbea H: The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development. Proc Natl Acad Sci U S A. 2003, 100: 199-204. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr592.asp#finke CrossRefPubMed

Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P: Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003, 160: 267-277. For the Faculty of 1000 evaluation of this article please see http://breast-cancer-research.com/reports/bcr592.asp#wolf CrossRefPubMedPubMedCentral

Title: Articles selected from Faculty of 1000 in March 2003
Author: Valerie Speirs
Publication date: 01-04-2003
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue 2/2003
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr595

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2003

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on preclinical and translational research

Host microenvironment in breast cancer development: Epithelial–mesenchymal transition in breast cancer development

New insights into the biological function of BRCA2 from its structural interactions

Akt kinases in breast cancer and the results of adjuvant therapy

Waist–hip ratio and breast cancer risk in urbanized Nigerian women

Articles selected from Faculty of 1000 in May 2003

Keynote webinar | Spotlight on antibody–drug conjugates in cancer